What is DigiSight Technologies?
DigiSight Technologies, Inc. operates at the intersection of mobile technology and ophthalmology. The company is best known for its Paxos Scope, a mobile ophthalmic camera that enables healthcare professionals to capture high-resolution images of the anterior segment and retina directly from a mobile device. These images are seamlessly integrated into the HIPAA-compliant Paxos cloud, facilitating secure, real-time communication and collaborative care among medical practitioners.
By digitizing the ophthalmic examination process, DigiSight addresses critical inefficiencies in traditional eye care delivery. The platform is designed to empower clinicians to make faster, more informed decisions, thereby improving patient outcomes and reducing the logistical burdens associated with specialized eye health monitoring. The company's leadership, comprised of seasoned ophthalmologists and technology veterans, has successfully positioned the firm as a key player in the digital health infrastructure space.
How much funding has DigiSight Technologies raised?
DigiSight Technologies has raised a total of $7.8M across 1 funding round:
Series B
$7.8M
Series B (2015): $7.8M with participation from Lagunita Capital and GE Ventures
Key Investors in DigiSight Technologies
Lagunita Capital
Lagunita Capital is a strategic investment firm focused on operational business management and identifying unrecognized sources of value to drive long-term growth.
GE Ventures
GE Ventures is the investment arm of General Electric, specializing in industrial and healthcare technology sectors with a focus on global infrastructure innovation.
What's next for DigiSight Technologies?
With the recent influx of capital, DigiSight Technologies is expected to prioritize the expansion of its Paxos platform, focusing on deeper integration with existing electronic health record systems and broader market penetration within large-scale healthcare networks. The strategic roadmap likely includes enhancing the diagnostic capabilities of the Paxos cloud and scaling its sales and support infrastructure to meet the demands of a growing enterprise client base.
As the digital health sector continues to prioritize remote monitoring and telehealth, DigiSight is uniquely positioned to capitalize on the shift toward decentralized care. Future growth will likely be driven by the continued adoption of its mobile diagnostic tools, which offer a scalable solution for health systems looking to optimize their ophthalmic service lines and improve the efficiency of patient care coordination.
